Plus Therapeutics, Inc.
PSTV
$0.5424
-$0.0855-13.62%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 129.60% | -345.84% | -35.80% | 2.24% | 9.84% |
| Total Depreciation and Amortization | -47.26% | 41.75% | -55.60% | 36.47% | 9.68% |
| Total Amortization of Deferred Charges | -- | -- | -- | -100.00% | -75.00% |
| Total Other Non-Cash Items | -152.10% | 5,696.76% | 124.49% | 10.91% | -656.18% |
| Change in Net Operating Assets | -213.14% | -160.60% | 1,621.15% | -105.99% | 262.77% |
| Cash from Operations | 6.06% | -409.66% | 67.09% | -220.00% | 74.52% |
| Capital Expenditure | -133.33% | 72.73% | 21.43% | 82.72% | -102.50% |
| Sale of Property, Plant, and Equipment | -100.00% | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -230.98% | 4,608.00% | 1,400.00% | 100.13% | -1,048.46% |
| Cash from Investing | -230.19% | 5,459.38% | 811.11% | 99.76% | -944.51% |
| Total Debt Issued | -100.00% | -- | -- | -100.00% | -- |
| Total Debt Repaid | 100.00% | -- | -- | 100.00% | -794.03% |
| Issuance of Common Stock | -80.74% | -- | -- | -100.00% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | 100.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -77.46% | -- | -- | -100.00% | 997.29% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -177.97% | 953.62% | 68.91% | -283.44% | 135.57% |